By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hyperion Therapeutics 

2000 Sierra Point Parkway
Suite 400
San Francisco  California  94005  U.S.A.
Phone: 1-650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


Company News
Clal Biotech (CLALF) Opts Out of Re-Acquiring Andromeda from Hyperion (HPTX) After Phase III Diabetes Drug Tanks 10/7/2015 7:45:40 AM
Horizon Pharma (HZNP) Completes Acquisition Of Hyperion Therapeutics (HPTX) 5/7/2015 11:34:23 AM
Horizon Pharma (HZNP) Announces Expiration Of HSR Waiting Period For Proposed Hyperion Therapeutics (HPTX) Acquisition 4/30/2015 11:10:11 AM
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/30/2015 7:40:34 AM
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015 6:44:24 AM
Hyperion Therapeutics (HPTX) To Present At 27th Annual ROTH Conference 3/6/2015 8:03:03 AM
Hyperion Therapeutics (HPTX) Observes Rare Disease Day 2015 2/27/2015 7:57:58 AM
Hyperion Therapeutics (HPTX) Announces Fourth Quarter And Full Year 2014 Financial Results 2/27/2015 7:30:24 AM
Hyperion Therapeutics (HPTX) To Present At The Cowen and Company 35th Annual Health Care Conference 2/26/2015 8:20:54 AM
Hyperion Therapeutics (HPTX) To Report Fourth Quarter And Full Year 2014 Financial Results After Market On February 26, 2015 2/20/2015 7:30:39 AM